Home › Psychotic Disorders › NCT06071858
Enhanced Coordinated Specialty Care for Early Psychosis
Cluster Randomized Trial of Enhanced Coordinated Specialty Care (CSC 2.0) for Early Psychosis
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * People undergoing an intake evaluation to CSC for first-episode psychosis in one of the following outpatient clinics: * McLean Hospital OnTrack (OnTrack Clinic) * Massachusetts General Hospital (FEPP Clinic) * Boston Medical Center (WRAP Clinic) * Cambridge Health Alliance (RISE Clinic) * UMass Memorial Health Care (STEP Clinic) * ServiceNet (PREP West) Exclusion Criteria: * None
About the study
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is:
• Does the addition of certain elements of care increase the number of visits in treatment for first-episode psychosis?
Participants will either:
* Receive care as usual (CSC) or * Receive care as usual (CSC) plus five additional care elements (CSC 2.0):
1. Individual peer support 2. Digital outreach 3. Care coordination 4. Multi-family group therapy 5. Cognitive remediation
Researchers will compare the standard of care (CSC) to CSC 2.0 to see if participants receiving CSC 2.0 have more visits to their clinic in their first year.
What is being tested
- Care Coordination (behavioral)
- Individual Peer Support (behavioral)
- Digital Outreach (behavioral)
- Cognitive Remediation (behavioral)
- Multi-Family Group Therapy (behavioral)
Sponsor: Mclean Hospital · Participants: 350 · Started: Feb 1, 2024
Contact the study team
- Dost Ongur, MD, PhD · Phone: 617-855-3922
- Jacqueline Dow, MPH · Phone: 617-855-3321
Official record on ClinicalTrials.gov — NCT06071858
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.